Rosiglitazone and the case for safety over certainty

JAMA. 2010 Jul 28;304(4):469-71. doi: 10.1001/jama.2010.954. Epub 2010 Jun 28.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Decision Making
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / mortality
  • Heart Failure / epidemiology*
  • Hypoglycemic Agents / adverse effects*
  • Meta-Analysis as Topic
  • Myocardial Infarction / epidemiology*
  • Pioglitazone
  • Risk
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • Pioglitazone